Andreas Schneeweiß
Goethe University Frankfurt(DE)German Cancer Research Center(DE)Heidelberg University(DE)University Hospital Heidelberg(DE)National Center for Tumor Diseases(DE)DKFZ-ZMBH Alliance(DE)NSABP Foundation(US)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Cancer Genomics and Diagnostics
Most-Cited Works
- → Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer(2018)2,535 cited
- → Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer(2015)2,084 cited
- → Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy(2017)2,068 cited
- → Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)(2013)1,241 cited
- → Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial(2019)1,171 cited
- →